Hepatitis C virus infection and its clearance alter circulating lipids: Implications for long‐term follow‐up
Kathleen E. Corey, Erin Kane, Craig Munroe, Lydia L. Barlow, Hui Zheng, Raymond T. Chung – 28 September 2009 – Hepatitis C associated hypolipidemia has been demonstrated in studies from Europe and Africa. In two linked studies, we evaluated the relationship between hepatitis C infection and treatment with lipid levels in an American cohort and determined the frequency of clinically significant posttreatment hyperlipidemia. First, a case‐control analysis of patients with and without hepatitis C was performed. The HCV Group consisted of 179 infected patients.